Second Marrow Transplants
| UPN . | Regimen . | Donor . | Day of Relapse . | Day of 2nd BMT . | 2nd Regimen . | 2nd Donor . | Survival From 2nd BMT (yr) . | COD After 2nd BMT . |
|---|---|---|---|---|---|---|---|---|
| 3318 | TBI | MMR | 364 | 378 | BuCy | MMR | 1.0 | Relapse |
| 3509 | BuCy | MMR | 347 | 363 | TBI | MMR | — | |
| 35096-150 | — | — | 5736-151 | 9446-151 | BCV | MMR | 3.56-151 | Relapse |
| 4054 | BuCy | MR | 78 | 100 | TBI | MR | >8.2 | — |
| 4654 | BuCy | MR | 52 | 105 | TBI | MR | >7.2 | — |
| 6128 | BuCy | AUTO | 420 | 490 | TBI | MMR | >3.5 | — |
| 6805 | BuCy | MMR | 189 | 234 | TBI | MMR | 0.2 | VOD |
| 7426 | TBI | MMR | 82 | 819 | ?6-152 | MMR | >2.5 | — |
| 7915 | BuCy | AUTO | 59 | 90 | TBI | URD | 0.1 | Relapse |
| 8218 | TBI | URD | 416 | 558 | BuTh | URD | >1.9 | — |
| UPN . | Regimen . | Donor . | Day of Relapse . | Day of 2nd BMT . | 2nd Regimen . | 2nd Donor . | Survival From 2nd BMT (yr) . | COD After 2nd BMT . |
|---|---|---|---|---|---|---|---|---|
| 3318 | TBI | MMR | 364 | 378 | BuCy | MMR | 1.0 | Relapse |
| 3509 | BuCy | MMR | 347 | 363 | TBI | MMR | — | |
| 35096-150 | — | — | 5736-151 | 9446-151 | BCV | MMR | 3.56-151 | Relapse |
| 4054 | BuCy | MR | 78 | 100 | TBI | MR | >8.2 | — |
| 4654 | BuCy | MR | 52 | 105 | TBI | MR | >7.2 | — |
| 6128 | BuCy | AUTO | 420 | 490 | TBI | MMR | >3.5 | — |
| 6805 | BuCy | MMR | 189 | 234 | TBI | MMR | 0.2 | VOD |
| 7426 | TBI | MMR | 82 | 819 | ?6-152 | MMR | >2.5 | — |
| 7915 | BuCy | AUTO | 59 | 90 | TBI | URD | 0.1 | Relapse |
| 8218 | TBI | URD | 416 | 558 | BuTh | URD | >1.9 | — |
Abbreviations: COD, cause of death; BCV, cyclophosphamide, etoposide, and carmustine; BuTh, busulfan + thiotepa; MMR, mismatched related donor; MR, matched related donor; URD, unrelated donor; AUTO, autologous.
Third transplant.
Interval relative to first BMT.
Second transplant performed at another institution.